Live feed
Filing
SC 13G/A
SC 13G/A0000902219-17-000550·FIVE PRIME THERAPEUTICS, INC.
Schedule 13G ownership disclosure
FIVE PRIME THERAPEUTICS INC
Security class unavailable · CUSIP: 33830X104
Event date: 2017-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,923,140
- Percent of class
- 10.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-17-000550
- Form type
- SC 13G/A
- Filer
- FIVE PRIME THERAPEUTICS, INC.
- CIK
- CIK 1175505
- Filed
- Jul 10, 2017
- Reporting period
- Jun 30, 2017
- Description
- Schedule 13G beneficial ownership